Medical Nanotechnology
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
47
NCT05507970
First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367
Phase: Phase 1
Role: Collaborator
Start: Jul 29, 2022
Completion: Jan 25, 2023
Loading map...